CT-Guide navigation is designed to assist physicians during CT-guided interventional diagnostic and therapeutic procedures such as percutaneous biopsies, ablations and marker placements in the lung and liver, according to the release.
“With today’s announcement, ActiViews further cements our commitment to become a leading provider of minimally invasive thoracic and abdominal surgical oncology solutions,” said Christopher von Jako, president of ActiViews, in the release. “With now our second successful clinical trial for the FDA with CT-Guide navigation, we are able to offer our customers an expanded indication from lung into liver and further clinical evidence of the efficacy of our unique and simple tool in these critical applications.”
ActiViews is based out of Wakefield, Mass.
Related Articles on FDA Clearances:
Abbott Receives FDA Clearance for Use of Femtosecond Laser for Arcuate Incisions
CurveBeam Receives FDA 510(k) Approval for the pedCAT 3D Foot and Ankle Scanner
Carestream Health Receives FDA Clearance for Mobile X-Ray System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
